Medical Disclaimer: This article is for general education only and is not medical advice. Prescription medications and supplements can carry risks, interactions, and contraindications. Do not start, stop, or change any medication or supplement without consulting a qualified clinician. Last reviewed: July 2026. See also: our longevity tools.
Rapamycin and Metformin have emerged as significant compounds in the quest for extended human longevity. Both drugs, initially developed for other medical conditions, are now among the most actively studied compounds in longevity research, though their benefits in healthy humans remain under investigation.
This article explores what current scientific studies reveal about their potential benefits and considerations for individuals over 45. Understanding the science behind these compounds is crucial for informed decisions about health and aging.
Key Takeaways
- Rapamycin shows promise in animal studies for lifespan extension, with some human trials indicating improvements in age-related physiological markers.
- Metformin, a well-established diabetes drug, demonstrates anti-aging effects in model organisms and reduces age-related disease incidence in humans, particularly those with diabetes.
- While research is ongoing, neither drug is currently a universally recommended anti-aging solution for healthy individuals over 45 without medical supervision.
Rapamycin: A Look at the mTOR Inhibitor
Rapamycin is an immunosuppressant drug primarily used to prevent organ transplant rejection. Its anti-aging potential stems from its ability to inhibit the mammalian target of rapamycin (mTOR) pathway. This pathway plays a crucial role in cell growth, metabolism, and aging.
What Longevity Research Shows for Rapamycin
Animal studies have consistently shown that rapamycin can extend lifespan in various organisms, including worms, flies, and mice. In humans, research is still in early stages and no clinical trial has demonstrated that rapamycin extends human lifespan. Some studies suggest it may improve certain physiological parameters associated with aging, such as immune function, but results are preliminary and not conclusive.
Metformin: Beyond Diabetes Management
Metformin is a widely prescribed medication for type 2 diabetes that works by reducing glucose production in the liver and improving insulin sensitivity. Beyond its glucose-lowering effects, metformin has garnered attention for its potential anti-aging properties. It activates the AMPK pathway, which is involved in cellular energy homeostasis and stress response.
Important Considerations for Individuals Over 45
For individuals over 45 considering these compounds, it is crucial to understand that neither is approved as an anti-aging drug, and neither should be considered a general anti-aging treatment. Their use for longevity purposes is off-label, meaning it is not supported by regulatory approval for that indication, and should be approached with caution. Consulting with a healthcare professional experienced in longevity medicine is strongly recommended before starting any new regimen. Do not begin either medication without a prescription and medical supervision.
Common Questions
Are Rapamycin and Metformin safe for anti-aging?
While generally safe for their approved uses, their long-term safety and efficacy specifically for anti-aging in healthy individuals are still under investigation. Potential side effects exist for both, so medical supervision is essential.
What is the TAME trial?
The Targeting Aging with Metformin (TAME) trial is a significant clinical study aiming to determine if metformin can delay the onset of age-related diseases and extend healthy lifespan in older adults without diabetes.
Can I take these drugs without a prescription?
Want to go deeper on longevity? Explore our longevity tools or get in touch.
No. Both rapamycin and metformin are prescription medications. They should only be taken under the supervision of a qualified healthcare provider who can monitor for side effects and interactions.